论文部分内容阅读
作者研究不同剂量及不同用药途径的心得安对甲亢病人血钙的影响。计甲状腺功能亢进(简称甲亢)病人25例,包括5例并发高钙血症患者。结果在高血钙组,静注心得安后血钙明显下降,自2.79±0.1降至2.58±0.2mmol/L。但口服160 mg/d 时,2例血钙仍高于正常,1例反较治疗前升高。当剂量增至320 mg/d 时,除1例仍处于边缘性高血钙(2.66mmol/L)外,其余血钙均明显下降。在正常血钙组中,口服心得安160mg/d 时,除2例发展成
The study of different doses and different routes of use of propranolol on hyperthyroidism patients with serum calcium. 25 cases of hyperthyroidism (referred to as hyperthyroidism) patients, including 5 cases of patients with hypercalcemia. The results in the hypercalcemia group, intravenous propranolol serum calcium decreased significantly, from 2.79 ± 0.1 to 2.58 ± 0.2mmol / L. However, oral 160 mg / d, 2 cases of serum calcium is still higher than normal, 1 case compared with before treatment increased. When the dose was increased to 320 mg / d, all the remaining serum calcium was significantly decreased except for one case of borderline hypercalcemia (2.66 mmol / L). In the normal serum calcium group, oral propranolol 160mg / d, except for 2 cases developed into